Say goodbye to trial and error when it comes to skin care. L’Oréal Groupe’s Cell BioPrint, unveiling today at CES in Las Vegas, takes the guesswork out of skin treatments by diagnosing skin cell biological markers and assessing their predisposition to certain ingredients found in beauty products.
L’Oréal researchers found that 90% of consumers are frustrated with skin treatment products. They are expensive, take a long time to produce results and often simply don’t work.
Cell BioPrint aims to change all that by analyzing the skin’s biomarkers to determine the best and most efficacious ingredients for each client’s individual skin type. The technology was born of a partnership between L’Oréal and Korean startup NanoEntek, which has hundreds of patents to its name.
The personalized skin analysis takes five minutes at any beauty counter. Lab-on-a-chip technology, NanoEntek’s science, identified unique biomarkers in the skin that can indicate key components of healthy-looking skin and longevity. It measures L’Oréal’s groundbreaking biomarkers in five minutes.
“There’s a biological marker that tells you whether retinol will work or not on your skin,” said Guive Balooch, L’Oréal Global Head of Research and Innovation’s Tech Incubator. “People use it for 10 years and find out that they are just guessing. It will measure skin cells’ responsiveness. In one minute, it will tell you the level of getting your skin condition under control in the future. It will also tell you if you’ll be responsive or unresponsive to certain ingredients to create a protocol.
“There are so many choices,” Balooch said, referring to treatment products. “All the advice given today is based on measurements. I’m excited about the product we are unveiling. Last year we launched a hair light pro and Colorsonic. This year, we’re unveiling a product for the skin. It’s the number one tension consumers feel. People want to reach a new level of artistry.”
Balooch said L’Oréal’s Longevity Integrative Science is a groundbreaking approach that reveals how mechanisms in the human body can affect skin’s age and appearance. It can tell how fast skin is aging and uncover the skin’s biological age with advice on how to slow it down, and can tell whether certain active ingredients will be efficacious.
The technology demonstrates the shift from reactive to proactive skin care. “At L’Oréal, we’re always looking toward the future with our long-standing beauty expertise,” said Barbara Lavernos, deputy CEO in charge of Research, Innovation and Technology at L’Oréal Group. “With skin being the largest organ and a key part of people’s well-being, we’re thrilled to unveil Cell BioPrint, an exclusive lab-on-a-chip technology coupled with our century-long skin science leadership.”
The global skincare market is expected to reach $125 billion in 2024, driven by consumers who want more information about their skin. According to L’Oréal, a survey of 2,000 skin care users in the U.S. found that 80% rely on trial and error to find what works for them with the average person reportedly trying seven cleansers before finding one they love.
BioPrint is easy to use. Apply a facial tape strip on your cheek then place into buffer solution. Load the solution into the BioPrint cartridge and insert it into the machine for analysis. While it processes the sample, the Skin Connect device takes several images of the face and administers a short questionnaire about skin concerns. BioPrint is scheduled to pilot with a L’Oréal brand in Asia in late 2025, overseen by the company’s team of over 4,000 scientists.
Last year, L’Oréal introduced HAPTA at CES, a product developed for use with L’Oréal’s prestige Lancôme brand. The technology, which was built on a spoon and fork and knife, allows people with disabilities to evenly and accurately apply makeup.
“It’s a beautiful product, it uses the core technology of Liftware, but it’s been optimized for use as an applicator of lipstick and makeup products, and so it’s quite incredible,” said Balooch. “Someone with Cerebral Palsy, someone who has a tremor, and someone who had a stroke can now apply the makeup products they always dreamed of applying, now that they have the system’s technology.”
The applicator requires an investment of about $199. “It would be a mistake to think that this population doesn’t have the spending power to buy it, but it’s not so expensive,” said Balooch. “We’ll make it as accessible as possible with regard to price. In the end, it’s a one-time investment. We’ll find ways to make it more accessible over time.”